lncRNA BCAR4 sponges miR‑370‑3p to promote bladder cancer progression via Wnt signaling

Zhang,Rongkui; Wang,Jiping; Jia,Er'na; Zhang,Jialiang; Liu,Nan; Chi,Changliang

doi:10.3892/ijmm.2019.4444

lncRNA BCAR4 sponges miR‑370‑3p to promote bladder cancer progression via Wnt signaling

Authors:
- Rongkui Zhang
- Jiping Wang
- Er'na Jia
- Jialiang Zhang
- Nan Liu
- Changliang Chi
View Affiliations

Affiliations: Department of Radiology, The First Hospital of Jilin University, Changchun, Jilin 130021, P.R. China, Department of Gastroenterology, China‑Japan Union Hospital of Jilin University, Changchun, Jilin 130033, P.R. China, Department of Emergency, The First Hospital of Jilin University, Changchun, Jilin 130021, P.R. China, Department of Anesthesiology, The First Hospital of Jilin University, Changchun, Jilin 130021, P.R. China, Department of Urology Surgery, The First Hospital of Jilin University, Changchun, Jilin 130021, P.R. China
Published online on: December 27, 2019 https://doi.org/10.3892/ijmm.2019.4444
Pages: 578-588
Copyright: © Zhang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Accumulating evidence suggests that the aberrant expression of long non‑coding RNAs (lncRNAs) is involved in the initiation, development and metastasis of bladder cancer (BC). Although several differentially expressed lncRNAs have been identified via lncRNA expression profiling of BC tissues, their functions and the molecular mechanisms underlying these functions remain to be fully elucidated. In the present study, elevated levels of lncRNA breast cancer anti‑estrogen receptor 4 (BCAR4) were identified in BC tissues compared with matched healthy tissues. Silencing of BCAR4 inhibited cell proliferation and induced apoptosis in BC cell lines 5637 and T24. Downregulation of BCAR4 led to the inactivation of Wnt signaling. Mechanistically, BCAR4 directly sponged microRNA (miR)‑370‑3p and elevated Wnt7a expression. Endogenous expression of Wnt7a reversed BCAR4 silencing‑mediated cell growth arrest and induction of apoptosis in BC cells accompanied with a re‑activation of Wnt signaling. Reverse transcription‑quantitative PCR indicated that there was a strong association between BCAR4, miR‑370‑3p and Wnt7a expression in tumors from patients with BC compared with healthy control tissues. In conclusion, results of the present study suggest that lncRNA BCAR4 promoted proliferation and survival of BC cells via downregulation of miR‑370‑3p. Therefore, lncRNA BCAR4 may be a lncRNA of oncogenic potential in BC.

View Figures

View References

1	Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar : PubMed/NCBI
2	Babjuk M, Bohle A, Burger M, Capoun O, Cohen D, Compérat EM, Hernández V, Kaasinen E, Palou J, Rouprêt M, et al: EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder: Update 2016. Eur Urol. 71:447–461. 2017. View Article : Google Scholar
3	Anastasiadis A and de Reijke TM: Best practice in the treatment of nonmuscle invasive bladder cancer. Ther Adv Urol. 4:13–32. 2012. View Article : Google Scholar : PubMed/NCBI
4	Shah JB, McConkey DJ and Dinney CP: New strategies in muscle-invasive bladder cancer: On the road to personalized medicine. Clin Cancer Res. 17:2608–2612. 2011. View Article : Google Scholar : PubMed/NCBI
5	Jarroux J, Morillon A and Pinskaya M: History, discovery, and classification of lncRNAs. Adv Exp Med Biol. 1008:1–46. 2017. View Article : Google Scholar : PubMed/NCBI
6	Adelman K and Egan E: Non-coding RNA: More uses for genomic junk. Nature. 543:183–185. 2017. View Article : Google Scholar : PubMed/NCBI
7	Salmena L, Poliseno L, Tay Y, Kats L and Pandolfi PP: A ceRNA hypothesis: The Rosetta Stone of a hidden RNA language? Cell. 146:353–358. 2011. View Article : Google Scholar : PubMed/NCBI
8	Martens-Uzunova ES, Bottcher R, Croce CM, Jenster G, Visakorpi T and Calin GA: Long noncoding RNA in prostate, bladder, and kidney cancer. Eur Urol. 65:1140–1151. 2014. View Article : Google Scholar : PubMed/NCBI
9	Jiang F, Qi W, Wang Y, Wang W and Fan L: lncRNA PEG10 promotes cell survival, invasion and migration by sponging miR-134 in human bladder cancer. Biomed Pharmacother. 114:1088142019. View Article : Google Scholar : PubMed/NCBI
10	Seitz AK, Christensen LL, Christensen E, Faarkrog K, Ostenfeld MS, Hedegaard J, Nordentoft I, Nielsen MM, Palmfeldt J, Thomson M, et al: Profiling of long non-coding RNAs identifies LINC00958 and LINC01296 as candidate oncogenes in bladder cancer. Sci Rep. 7:3952017. View Article : Google Scholar : PubMed/NCBI
11	Feng SQ, Zhang XY, Fan HT, Sun QJ and Zhang M: Up-regulation of LncRNA MEG3 inhibits cell migration and invasion and enhances cisplatin chemosensitivity in bladder cancer cells. Neoplasma. 65:925–932. 2018. View Article : Google Scholar : PubMed/NCBI
12	Pan J, Li X, Wu W, Xue M, Hou H, Zhai W and Chen W: Long non-coding RNA UCA1 promotes cisplatin/gemcitabine resistance through CREB modulating miR-196a-5p in bladder cancer cells. Cancer Lett. 382:64–76. 2016. View Article : Google Scholar : PubMed/NCBI
13	Li N, Gao WJ and Liu NS: LncRNA BCAR4 promotes proliferation, invasion and metastasis of non-small cell lung cancer cells by affecting epithelial-mesenchymal transition. Eur Rev Med Pharmacol Sci. 21:2075–2086. 2017.PubMed/NCBI
14	Zou R, Chen X, Jin X, Li S, Ou R, Xue J, Yan X, Chen L, Hu Y and Zhu H: Up-regulated BCAR4 contributes to proliferation and migration of cervical cancer cells. Surg Oncol. 27:306–313. 2018. View Article : Google Scholar : PubMed/NCBI
15	Huang X, Zhu H, Gao Z, Li J, Zhuang J, Dong Y, Shen B, Li M, Zhou H, Guo H, et al: Wnt7a activates canonical Wnt signaling, promotes bladder cancer cell invasion, and is suppressed by miR-370-3p. J Biol Chem. 293:6693–6706. 2018. View Article : Google Scholar : PubMed/NCBI
16	Klaus A and Birchmeier W: Wnt signalling and its impact on development and cancer. Nat Rev Cancer. 8:387–398. 2008. View Article : Google Scholar : PubMed/NCBI
17	Teng Y, Wang X, Wang Y and Ma D: Wnt/beta-catenin signaling regulates cancer stem cells in lung cancer A549 cells. Biochem Biophys Res Commun. 392:373–379. 2010. View Article : Google Scholar : PubMed/NCBI
18	MacLean JA II, King ML, Okuda H and Hayashi K: WNT7A Regulation by miR-15b in ovarian cancer. PLoS One. 11:e01561092016. View Article : Google Scholar : PubMed/NCBI
19	Wang L, Wang X and Jiang X: miR-127 suppresses gastric cancer cell migration and invasion via targeting Wnt7a. Oncol Lett. 17:3219–3226. 2019.PubMed/NCBI
20	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2-Delta Delta C (T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar
21	Wang L, Chunyan Q, Zhou Y, He Q, Ma Y, Ga Y and Wang X: BCAR4 increase cisplatin resistance and predicted poor survival in gastric cancer patients. Eur Rev Med Pharmacol Sci. 21:4064–4070. 2017.PubMed/NCBI
22	Ouyang S, Zheng X, Zhou X, Chen Z, Yang X and Xie M: LncRNA BCAR4 promotes colon cancer progression via activating Wnt/β-catenin signaling. Oncotarget. 8:92815–92826. 2017. View Article : Google Scholar : PubMed/NCBI
23	Cai Z, Wu Y, Li Y, Ren J and Wang L: BCAR4 activates GLI2 signaling in prostate cancer to contribute to castration resistance. Aging (Albany NY). 10:3702–3712. 2018. View Article : Google Scholar
24	Wei L, Yi Z, Guo K and Long X: Long noncoding RNA BCAR4 promotes glioma cell proliferation via EGFR/PI3K/AKT signaling pathway. J Cell Physiol. 234:23608–23617. 2019. View Article : Google Scholar : PubMed/NCBI
25	Yang H, Yan L, Sun K, Sun X, Zhang X, Cai K and Song T: lncRNA BCAR4 increases viability, invasion, and migration of non-small cell lung cancer cells by targeting glioma-associated oncogene 2 (GLI2). Oncol Res. 27:359–369. 2019. View Article : Google Scholar
26	Cao MX, Jiang YP, Tang YL and Liang XH: The crosstalk between lncRNA and microRNA in cancer metastasis: Orchestrating the epithelial-mesenchymal plasticity. Oncotarget. 8:12472–12483. 2017.
27	Rinn JL and Chang HY: Genome regulation by long noncoding RNAs. Annu Rev Biochem. 81:145–166. 2012. View Article : Google Scholar : PubMed/NCBI
28	Chen JQ, Papp G, Szodoray P and Zeher M: The role of microRNAs in the pathogenesis of autoimmune diseases. Autoimmun Rev. 15:1171–1180. 2016. View Article : Google Scholar : PubMed/NCBI
29	Lawrie CH: MicroRNAs and haematology: Small molecules, big function. Br J Haematol. 137:503–512. 2007. View Article : Google Scholar : PubMed/NCBI
30	Lu J, Getz G, Miska EA, Alvarez-Saavedra E, Lamb J, Peck D, Sweet-Cordero A, Ebert BL, Mak RH, Ferrando AA, et al: MicroRNA expression profiles classify human cancers. Nature. 435:834–838. 2005. View Article : Google Scholar : PubMed/NCBI
31	Ouyang S, Zhou X, Chen Z, Wang M, Zheng X and Xie M: LncRNA BCAR4, targeting to miR-665/STAT3 signaling, maintains cancer stem cells stemness and promotes tumorigenicity in colorectal cancer. Cancer Cell Int. 19:722019. View Article : Google Scholar : PubMed/NCBI
32	Li Z, Dou P, Liu T and He S: Application of long noncoding RNAs in osteosarcoma: Biomarkers and therapeutic targets. Cell Physiol Biochem. 42:1407–1419. 2017. View Article : Google Scholar : PubMed/NCBI
33	Yoshino H, Chiyomaru T, Enokida H, Kawakami K, Tatarano S, Nishiyama K, Nohata N, Seki N and Nakagawa M: The tumour-suppressive function of miR-1 and miR-133a targeting TAGLN2 in bladder cancer. Br J Cancer. 104:808–818. 2011. View Article : Google Scholar : PubMed/NCBI
34	Wang C, Chen Z, Ge Q, Hu J, Li F, Hu J, Xu H, Ye Z and Li LC: Up-regulation of p21(WAF1/CIP1) by miRNAs and its implications in bladder cancer cells. FEBS Lett. 588:4654–4664. 2014. View Article : Google Scholar : PubMed/NCBI
35	Wang C, Ge Q, Chen Z, Hu J, Li F and Ye Z: Promoter-associated endogenous and exogenous small RNAs suppress human bladder cancer cell metastasis by activating p21 (CIP1/WAF1) expression. Tumour Biol. 37:6589–6598. 2016. View Article : Google Scholar
36	Yamane K, Naito H, Wakabayashi T, Yoshida H, Muramatsu F, Iba T, Kidoya H and Takakura N: Regulation of SLD5 gene expression by miR-370 during acute growth of cancer cells. Sci Rep. 6:309412016. View Article : Google Scholar : PubMed/NCBI